A Case of Hemophilia B Diagnosed after Rhinosinus Surgery in 37 Year-Old Patient
Hae-Dong KIM; Ick-Soo CHOI.
Korean Journal of Otolaryngology - Head and Neck Surgery
; : 308-311, 2018.
ArtÃculo en Ko | WPRIM | ID: wpr-714968
Documentos relacionados
How to fix the NHS.
FIX It in One Go: Enhanced Factor IX Gene Therapy for Hemophilia B.
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
The Molecular Basis of FIX Deficiency in Hemophilia B.
Closing In on Treatment for Hemophilia B.
The current challenges faced by people with hemophilia B.
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B.
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B. Reply.
Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B.
Real-world outcomes with recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis: Longitudinal follow-up in a national adult cohort.